BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28794434)

  • 1. Protective role of cellular prion protein against TNFα-mediated inflammation through TACE α-secretase.
    Ezpeleta J; Boudet-Devaud F; Pietri M; Baudry A; Baudouin V; Alleaume-Butaux A; Dagoneau N; Kellermann O; Launay JM; Schneider B
    Sci Rep; 2017 Aug; 7(1):7671. PubMed ID: 28794434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
    Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
    Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling.
    Ribeiro LW; Pietri M; Ardila-Osorio H; Baudry A; Boudet-Devaud F; Bizingre C; Arellano-Anaya ZE; Haeberlé AM; Gadot N; Boland S; Devineau S; Bailly Y; Kellermann O; Bencsik A; Schneider B
    Part Fibre Toxicol; 2022 Jul; 19(1):48. PubMed ID: 35840975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular prion protein coupling to TACE-dependent TNF-alpha shedding controls neurotransmitter catabolism in neuronal cells.
    Pradines E; Loubet D; Mouillet-Richard S; Manivet P; Launay JM; Kellermann O; Schneider B
    J Neurochem; 2009 Aug; 110(3):912-23. PubMed ID: 19457070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the neurospecificity of Prion protein signaling.
    Schneider B; Pietri M; Pradines E; Loubet D; Launay JM; Kellermann O; Mouillet-Richard S
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):169-86. PubMed ID: 21196165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
    Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
    Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular prion protein signaling in serotonergic neuronal cells.
    Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
    Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of STI1-mediated neuronal survival and differentiation in disease-associated mutations of prion protein.
    Landemberger MC; de Oliveira GP; Machado CF; Gollob KJ; Martins VR
    J Neurochem; 2018 Jun; 145(5):409-416. PubMed ID: 29337365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of RhoA activity by the cellular prion protein.
    Kim HJ; Choi HS; Park JH; Kim MJ; Lee HG; Petersen RB; Kim YS; Park JB; Choi EK
    Cell Death Dis; 2017 Mar; 8(3):e2668. PubMed ID: 28300846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuritogenesis: the prion protein controls β1 integrin signaling activity.
    Loubet D; Dakowski C; Pietri M; Pradines E; Bernard S; Callebert J; Ardila-Osorio H; Mouillet-Richard S; Launay JM; Kellermann O; Schneider B
    FASEB J; 2012 Feb; 26(2):678-90. PubMed ID: 22038049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.
    Cissé M; Duplan E; Guillot-Sestier MV; Rumigny J; Bauer C; Pagès G; Orzechowski HD; Slack BE; Checler F; Vincent B
    J Biol Chem; 2011 Aug; 286(33):29192-29206. PubMed ID: 21586567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion and TNFα: TAC(E)it agreement between the prion protein and cell signaling.
    Stella R; Massimino ML; Sorgato MC; Bertoli A
    Cell Cycle; 2010 Dec; 9(23):4616-21. PubMed ID: 21099358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons.
    Walsh KP; Minamide LS; Kane SJ; Shaw AE; Brown DR; Pulford B; Zabel MD; Lambeth JD; Kuhn TB; Bamburg JR
    PLoS One; 2014; 9(4):e95995. PubMed ID: 24760020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neuritogenesis Defects and Prion Accumulation.
    Alleaume-Butaux A; Nicot S; Pietri M; Baudry A; Dakowski C; Tixador P; Ardila-Osorio H; Haeberlé AM; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
    PLoS Pathog; 2015 Aug; 11(8):e1005073. PubMed ID: 26241960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells.
    Pietri M; Caprini A; Mouillet-Richard S; Pradines E; Ermonval M; Grassi J; Kellermann O; Schneider B
    J Biol Chem; 2006 Sep; 281(38):28470-9. PubMed ID: 16864581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase.
    Cissé MA; Gandreuil C; Hernandez JF; Martinez J; Checler F; Vincent B
    Biochem Biophys Res Commun; 2006 Aug; 347(1):254-60. PubMed ID: 16806063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.
    Hirsch TZ; Martin-Lannerée S; Reine F; Hernandez-Rapp J; Herzog L; Dron M; Privat N; Passet B; Halliez S; Villa-Diaz A; Lacroux C; Klein V; Haïk S; Andréoletti O; Torres JM; Vilotte JL; Béringue V; Mouillet-Richard S
    Mol Neurobiol; 2019 Mar; 56(3):2159-2173. PubMed ID: 29998397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
    Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
    Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Secretase-derived cleavage of cellular prion yields biologically active catabolites with distinct functions.
    Guillot-Sestier MV; Checler F
    Neurodegener Dis; 2012; 10(1-4):294-7. PubMed ID: 22261541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
    Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
    FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.